CoreCap Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $642K | Buy |
1,442
+641
| +80% | +$285K | 0.03% | 455 |
|
|
2025
Q1 | $388K | Sell |
801
-425
| -35% | -$206K | 0.02% | 519 |
|
|
2024
Q4 | $494K | Sell |
1,226
-6,622
| -84% | -$2.67M | 0.02% | 486 |
|
|
2024
Q3 | $3.65M | Buy |
7,848
+7,154
| +1,031% | +$3.33M | 0.17% | 117 |
|
|
2024
Q2 | $325K | Sell |
694
-1,194
| -63% | -$560K | 0.03% | 292 |
|
|
2024
Q1 | $789K | Buy |
1,888
+395
| +26% | +$165K | 0.04% | 329 |
|
|
2023
Q4 | $607K | Buy |
1,493
+793
| +113% | +$323K | 0.04% | 319 |
|
|
2023
Q3 | $243K | Buy |
+700
| New | +$243K | 0.02% | 460 |
|
|
2022
Q4 | $378K | Sell |
1,309
-4,719
| -78% | -$1.36M | 0.03% | 407 |
|
|
2022
Q3 | $1.75M | Buy |
6,028
+254
| +4% | +$73.5K | 0.15% | 126 |
|
|
2022
Q2 | $1.63M | Buy |
+5,774
| New | +$1.63M | 0.13% | 129 |
|
|
2022
Q1 | – | Sell |
-372
| Closed | -$82K | – | 2071 |
|
|
2021
Q4 | $82K | Buy |
+372
| New | +$82K | 0.01% | 832 |
|